4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-012536
CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.50 ($22,500)
- CHIEF FINANCIAL OFFICER acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hohl Benjamin · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,000 | $2.48 | $2,480 | 1,000 | D |
| 2024-05-03 | Sale : show line 2 in the form 10b5-1 | −1,000 | $22.50 | $22,500 | 0 | D |
| Open-market sales · 1,000 sh · avg $22.50 · $22,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-03 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −1,000 | 221,120 | D |
Loading xslF345X05/form4-05072024_100528.xml…